Literature DB >> 16633913

Maternal use of recreational drugs and neuroblastoma in offspring: a report from the Children's Oncology Group (United States).

Elizabeth C Bluhm1, Julie Daniels, Brad H Pollock, Andrew F Olshan.   

Abstract

OBJECTIVE: To evaluate whether maternal use of recreational drugs around conception and pregnancy influences the risk of childhood neuroblastoma.
METHODS: Self-reported use of recreational drugs from one month prior to pregnancy until diagnosis was assessed among mothers of 538 children with neuroblastoma (diagnosed 1992-1994 and identified through the Children's Cancer Group and Pediatric Oncology Group) and 504 age-matched controls (identified by random-digit dialing). Odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional logistic regression, adjusting for age at diagnosis and household income.
RESULTS: Maternal use of any illicit or recreational drug around pregnancy was associated with an increased risk of neuroblastoma in offspring (OR = 1.82, 95% CI: 1.13, 3.00), particularly use of marijuana in the first trimester of pregnancy (OR = 4.75, 95% CI: 1.55, 16.48). Marijuana use in the month before pregnancy did not increase risk. The effect of gestational marijuana exposure was strongest in subjects diagnosed before age one. Evaluation of recreational drugs other than marijuana was limited by infrequent use, and analyses of drug use by fathers were not carried out due to missing data.
CONCLUSIONS: Maternal recreational drug use and marijuana use during pregnancy were associated with increased risk of neuroblastoma in offspring. Further examination of these drugs and the risk of childhood cancer is warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16633913     DOI: 10.1007/s10552-005-0580-3

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  13 in total

1.  Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.

Authors:  Catherine Lombard; Venkatesh L Hegde; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2011-08-10       Impact factor: 4.030

Review 2.  An epidemiologic review of marijuana and cancer: an update.

Authors:  Yu-Hui Jenny Huang; Zuo-Feng Zhang; Donald P Tashkin; Bingjian Feng; Kurt Straif; Mia Hashibe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01       Impact factor: 4.254

Review 3.  Epigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in Offspring.

Authors:  Elizabeth E Zumbrun; Jessica M Sido; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-25       Impact factor: 4.147

4.  Nonmedical Cannabis Use: Patterns and Correlates of Use, Exposure, and Harm, and Cancer Risk.

Authors:  Amy M Cohn; Benjamin C Blount; Mia Hashibe
Journal:  J Natl Cancer Inst Monogr       Date:  2021-11-28

Review 5.  The analgesic potential of cannabinoids.

Authors:  Jaseena Elikkottil; Jaseena Elikottil; Pankaj Gupta; Kalpna Gupta
Journal:  J Opioid Manag       Date:  2009 Nov-Dec

6.  Comparability and representativeness of control groups in a case-control study of infant leukemia: a report from the Children's Oncology Group.

Authors:  Susan E Puumala; Logan G Spector; Leslie L Robison; Greta R Bunin; Andrew F Olshan; Amy M Linabery; Michelle A Roesler; Cindy K Blair; Julie A Ross
Journal:  Am J Epidemiol       Date:  2009-06-04       Impact factor: 4.897

Review 7.  Cannabinoid exposure during pregnancy and its impact on immune function.

Authors:  Catherine Dong; Jingwen Chen; Amy Harrington; K Yaragudri Vinod; Muralidhar L Hegde; Venkatesh L Hegde
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

Review 8.  Smoking in pregnancy and lactation: a review of risks and cessation strategies.

Authors:  Adrienne Einarson; Sara Riordan
Journal:  Eur J Clin Pharmacol       Date:  2009-01-24       Impact factor: 2.953

9.  Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 3 - spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  Arch Public Health       Date:  2022-03-30

10.  Temporal clustering of neuroblastic tumours in children and young adults from Northern England.

Authors:  Colin R Muirhead; Deborah A Tweddle; Nermine O Basta; Richard J Q McNally
Journal:  Environ Health       Date:  2015-09-04       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.